| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |